Cresset Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.35M	Sell	383,786 -74,000	-16%	-$237K	0.01%	676
2025 Q4	$1.25M	Buy	457,786 +267,300	+140%	+$618K	0.01%	714
2025 Q3	$413K	Buy	190,486 +213	+0.1%	+$503	﹤0.01%	1109
2025 Q2	$327K	Buy	190,273 +112,000	+143%	+$279K	﹤0.01%	1102
2025 Q1	$261K	Sell	78,273 -29	-0%	-$150	﹤0.01%	1396
2024 Q4	$579K	Sell	78,302 -2,507	-3%	-$23.2K	﹤0.01%	1016
2024 Q3	$759K	Buy	80,809 +866	+1%	+$8.21K	﹤0.01%	1300
2024 Q2	$641K	Buy	79,943 +8,917	+13%	+$95.6K	﹤0.01%	1324
2024 Q1	$1.05M	Sell	71,026 -5,714	-7%	-$66.5K	0.01%	951
2023 Q4	$624K	Buy	76,740 +31,172	+68%	+$163K	﹤0.01%	1109
2023 Q3	$207K	Buy	45,568 +13,276	+41%	+$86.7K	﹤0.01%	1609
2023 Q2	$227K	Buy	32,292 +1,292	+4%	+$9.25K	﹤0.01%	1672
2023 Q1	$189K	Hold	31,000	–	–	﹤0.01%	749
2022 Q4	$198K	Sell	31,000 -14,000	-31%	-$109K	﹤0.01%	638
2022 Q3	$431K	Buy	45,000 +20,968	+87%	+$242K	0.01%	557
2022 Q2	$265K	Sell	24,032 -4,762	-17%	-$62.4K	﹤0.01%	747
2022 Q1	$479K	Buy	28,794 +9,407	+49%	+$145K	0.01%	619
2021 Q4	$369K	Buy	19,387 +495	+3%	+$10.9K	﹤0.01%	802
2021 Q3	$466K	Sell	18,892 -4,174	-18%	-$98.4K	0.01%	650
2021 Q2	$600K	Buy	23,066 +12,531	+119%	+$326K	0.01%	504
2021 Q1	$333K	Buy	+10,535	New	+$437K	0.01%	628